Lipid Nanoparticles Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2032

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Lipid Nanoparticles Market

4.1. Industry Value Chain Analysis
4.1.1. Research and Development
4.1.2. Manufacturing and Production
4.1.3. Quality Control and Testing
4.1.4. Regulatory Approval
4.1.5. End Users

4.2. Industry Outlook 
4.2.1. Recent Developments & Future Prospect in the Lipid Nanoparticles Market
4.2.2. Development of mRNA, DNA, and siRNA Lipid Nanoparticles vaccines for COVID-19 and Other Vaccines
4.2.3. Overview of Vaccine Development and Approval Stages
4.2.4. Timeline of some key milestones for lipid nanoparticle development

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Opportunity
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019 - 2032

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping

5.1. Key Insight

5.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
5.2.1. Solid Lipid Nanoparticles (SLNs)
5.2.2. Nanostructured Lipid Carriers (NLCs)
5.2.3. Liposomes
5.2.4. Lipid Nano Emulsions (NLEs)
5.2.5. Double-Layered or Bilayer Lipid Nanoparticles (BLNs)
5.2.5.1. Supported Lipid Bilayers (SLB)
5.2.5.2. Hybrid Lipid Bilayers (HLB)
5.2.6. Others

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
6.2.1. Drug Delivery System
6.2.2. Gene Therapeutics
6.2.2.1. Cancer
6.2.2.2. Genetic Diseases
6.2.2.3. Infectious Diseases
6.2.2.4. Others
6.2.3. Cosmetics
6.2.4. Research

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Academic & Research Institutes
7.2.3. Cosmetic manufacturers
7.2.4. Others

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
8.2.1. North America
8.2.1.1. The U.S.
8.2.1.2. Canada
8.2.1.3. Mexico
8.2.2. Europe
8.2.2.1. Western Europe
8.2.2.1.1. The UK
8.2.2.1.2. Germany
8.2.2.1.3. France
8.2.2.1.4. Italy
8.2.2.1.5. Spain
8.2.2.1.6. Rest of Western Europe
8.2.2.2. Eastern Europe
8.2.2.2.1. Poland 
8.2.2.2.2. Russia
8.2.2.2.3. Rest of Eastern Europe
8.2.3. Asia Pacific
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia & New Zealand
8.2.3.5. South Korea
8.2.3.6. ASEAN
8.2.3.7. Rest of Asia Pacific
8.2.4. Middle East & Africa
8.2.4.1. UAE
8.2.4.2. Saudi Arabia
8.2.4.3. South Africa
8.2.4.4. Rest of MEA
8.2.5. South America
8.2.5.1. Argentina
8.2.5.2. Brazil
8.2.5.3. Rest of South America

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
9.2.1. By Type
9.2.2. By Application
9.2.3. By End Users
9.2.4. By Country

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
10.2.1. By Type
10.2.2. By Application
10.2.3. By End Users
10.2.4. By Country

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
11.2.1. By Type
11.2.2. By Application
11.2.3. By End Users
11.2.4. By Country

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
12.2.1. By Type
12.2.2. By Application
12.2.3. By End Users
12.2.4. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
13.2.1. By Type
13.2.2. By Application
13.2.3. By End Users
13.2.4. By Country

14.1. Acuitas Therapeutics
14.2. Alnylam Pharmaceuticals
14.3. Amgen Inc.
14.4. Arbutus Biopharma
14.5. Arcturus Therapeutics
14.6. Arranta Bio
14.7. Avanti Polar Lipids
14.8. BioNTech SE
14.9. CordenPharma International
14.10. Dicerna Pharmaceuticals
14.11. Evonik Industries AG
14.12. Exelead
14.13. Gattefossé
14.14. Genevant Sciences
14.15. Helix Biotech, Inc.
14.16. IOI Oleo GmbH
14.17. Lipoid GmbH
14.18. Merck KGaA
14.19. Moderna, Inc.
14.20. Pfizer Inc.
14.21. Precision NanoSystems Inc.
14.22. PTS 
14.23. Sanofi SA
14.24. Sirnaomics
14.25. Wacker Chemie AG
14.26. Other Prominent Players